Adam E. Fine, Windham Venture Partners

Adam E. Fine, Co-Founder and CEO of Windham Venture Partners, invests in early-stage healthcare companies. See sector focus and contact routes.

About Adam E. Fine

Adam E. Fine, Co-Founder and CEO of Windham Venture Partners, invests in early-stage healthcare companies, specifically targeting seed to Series A rounds in medical technology (Class II/III devices) and digital health with check sizes ranging from approximately $550K to $45M. His notable portfolio includes Alto Neuroscience, Valera Health, SubjectWell, and RxWare, where he serves as a Board Director. Fine's distinctive thesis focuses on backing transformative technologies that address unmet medical needs to improve clinical outcomes and expand access to quality healthcare.

Adam E. Fine at a glance

Role
Co-Founder, Chief Executive Officer & General Partner
Organization
Windham Venture Partners
Location
New York, NY
Investor type
Venture Capital
Focus areas
Healthcare Devices and Supplies

Frequently asked about Adam E. Fine

What does Adam E. Fine invest in?
Adam E. Fine at Windham Venture Partners (New York, NY) — sector focus: Healthcare Devices and Supplies.
How do I contact Adam E. Fine?
Adam E. Fine's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Adam E. Fine based?
Adam E. Fine is based in New York, NY.

StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in New York.

Investors similar to Adam E. Fine (20)

Browse related investor lists (2)

Compare Adam E. Fine (8)

Investors like Adam E. Fine · Full investor directory · Investor access · Company funding database